24-Month Outcomes of Ahmed ClearPath ® Glaucoma Drainage Device for Refractory Glaucoma.

Syril DorairajLeticia A Checo Isabella V WagnerRichard D Ten HulzenAbhimanyu S Ahuja

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

To our knowledge, this is the second long-term study evaluating the efficacy of the Ahmed ClearPath drainage device in adult patients, and the first study with 24-months follow-up. The ACP device is safe and effective at reducing both IOP and medication burdens in patients with severe POAG. Additionally, minimal short-term complications were noted with no long-term adverse effects, increasing comfort for both the surgeon and the patient.

Keyphrases

healthcare
ultrasound guided
emergency department
risk factors
skeletal muscle
weight loss
optical coherence tomography
glycemic control